RNS Number:5958N
ReGen Therapeutics PLC
16 July 2003


ReGen Therapeutics Plc
Embargoed until 7am 16 July 2003


ReGen Therapeutics Plc


SUBSTANTIAL SHAREHOLDING


London, UK - 16 May, 2003: ReGen Therapeutics Plc (the "Company") announces that
on 15 July 2003 it received notification from Mr Colin Blackbourn that he is
beneficially interested in 7,000,000 ordinary shares of the Company representing
3.1% of the current issued share capital of the Company.


For further information, please contact:
Andrew Marshall
Marshall Robinson Roe
Tel No 020 7489 2033






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
HOLEAXXSFDLDEFE